Associate Professor Chris John Jackson
Director, Sutton Laboratories E25 - Royal North Shore Hospital
| ![]() |
Research interests
Dr Jackson's research focuses on cellular and molecular mechanisms of inflammation. We have a special interest in two groups of enzymes known as the matrix metalloproteinases and the serine proteases. Novel molecular biological techniques are used to manipulate cellular systems. Some interesting recent discoveries have come from our work investigating the mechanisms of action of one of these enzymes, activated protein C (APC). Our experiments using cultured cells and animal wounding models provide very strong evidence that APC accelerates wound healing. This work extends beyond cutaneous ulcers and has application to the healing of other tissues such as cartilage and bone that have been damaged by either disease, such as arthritis, or injury. Currently we are running 2 clinical trials to examine the efficacy of APC to treat chronic leg ulcers and burns.
Two provisional patent applications for new therapeutic interventions have arisen from work performed in the Sutton laboratories.
Publications
2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003
2009 | ||
| ||
2008 | ||
| ||
2007 | ||
| ||
2006 | ||
| ||
2005 | ||
| ||
2004 | ||
| ||
2003 | ||
| ||
Current national competitive grants*
2009
Novel pathways involving APC and PAR-2 in cartilage degradation in osteoarthritis
Little C, Jackson C
NHMRC Project Grants ($431,000 over 3 years)
2008
Activated protein C utilises protease activated receptors and epidermal growth factor receptor to heal wounds
Jackson C, Xue M
NHMRC Project Grant ($228,750 over 3 years)
* Grants administered through the University of Sydney


